Introduction
India's pharmaceutical industry is prospering, with
tremendous expansion over the last few decades. The Indian
government is working hard to promote this business by enacting and
implementing laws that are in line with international norms.
Intellectual property rights protection is becoming increasingly
important for businesses as the market expands and industry
participants invest. Despite the fact that Section 13 of the Trade
Marks Act of 1999 prohibits the use of chemical names as
trademarks, it is normal practise to name a drug after the organ it
treats ("Liv" for the liver, for example), the condition
it cures, or the treatment's principal ingredient.Since a
generic organ, disease, or ingredient cannot be trademarked, no one
can own it. There is a profusion of similar and often confusing
trademarks for drugs as a result of the Trade Marks Registry
enabling brand names containing the primary chemical ingredient,
organ, or ailment to be registered.
